Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease.

de Souza LC, Corlier F, Habert MO, Uspenskaya O, Maroy R, Lamari F, Chupin M, Lehéricy S, Colliot O, Hahn-Barma V, Samri D, Dubois B, Bottlaender M, Sarazin M.

Brain. 2011 Jul;134(Pt 7):2036-43. doi: 10.1093/brain/awr130.

PMID:
21705422
[PubMed - indexed for MEDLINE]
Free Article
2.

The dynamic marker hypothesis of Alzheimer's disease and its implications for clinical imaging.

Cavedo E, Frisoni GB.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):237-49. Review.

PMID:
21532538
[PubMed - indexed for MEDLINE]
3.

Amyloid-β and τ biomarkers in Parkinson's disease-dementia.

Buongiorno M, Compta Y, Martí MJ.

J Neurol Sci. 2011 Nov 15;310(1-2):25-30. doi: 10.1016/j.jns.2011.06.046. Epub 2011 Jul 20. Review.

PMID:
21764078
[PubMed - indexed for MEDLINE]
4.

Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.

McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB, et al.

CMAJ. 1986 Mar 15;134(6):597-607. Review.

PMID:
3512063
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.

Marksteiner J, Hinterhuber H, Humpel C.

Drugs Today (Barc). 2007 Jun;43(6):423-31. Review.

PMID:
17612711
[PubMed - indexed for MEDLINE]
6.

Alzheimer's disease: genetic basis and amyloid imaging as endophenotype.

Berti V, Nacmias B, Bagnoli S, Sorbi S.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):225-36. Review.

PMID:
21532537
[PubMed - indexed for MEDLINE]
7.

Molecular imaging of dementia.

Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T.

Psychogeriatrics. 2012 Jun;12(2):106-14. doi: 10.1111/j.1479-8301.2012.00409.x. Review.

PMID:
22712644
[PubMed - indexed for MEDLINE]
8.

[An overview of biomarkers in Alzheimer's disease].

Rong XF, Wang XL.

Yao Xue Xue Bao. 2012 May;47(5):551-7. Review. Chinese.

PMID:
22811995
[PubMed - indexed for MEDLINE]
9.

[Markers of prodromal Alzheimer's disease].

de Souza LC, Sarazin M, Uspenskaya O, Habert MO, Lamari F, Lehéricy S, Dubois B.

Rev Neurol (Paris). 2012 Nov;168(11):815-24. doi: 10.1016/j.neurol.2012.07.005. Epub 2012 Sep 1. Review. French.

PMID:
22944619
[PubMed - indexed for MEDLINE]
10.

Molecular neuroimaging in Alzheimer's disease.

Matsuda H, Imabayashi E.

Neuroimaging Clin N Am. 2012 Feb;22(1):57-65, viii. doi: 10.1016/j.nic.2011.11.005. Epub 2011 Dec 6. Review.

PMID:
22284733
[PubMed - indexed for MEDLINE]
11.

Cerebrospinal fluid biomarkers of Alzheimer's disease.

Fagan AM, Holtzman DM.

Biomark Med. 2010 Feb;4(1):51-63. doi: 10.2217/BMM.09.83. Review.

PMID:
20361010
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms].

Villain N, Chételat G, Desgranges B, Eustache F.

Biol Aujourdhui. 2010;204(2):145-58. doi: 10.1051/jbio/2010010. Epub 2010 Jun 21. Review. French.

PMID:
20950559
[PubMed - indexed for MEDLINE]
13.

[Imaging diagnosis of Alzheimer's disease].

Mänz C, Reimold M, Bender B, Bares R, Ernemann U, Horger M.

Rofo. 2012 Dec;184(12):1079-82. doi: 10.1055/s-0032-1319030. Epub 2012 Dec 4. Review. German. No abstract available.

PMID:
23212812
[PubMed - indexed for MEDLINE]
14.

[Dementia: progress in diagnosis and treatment; Topics; V. Recent topics; 1. Biomarkers for Alzheimer's disease and other dementia].

Tokuda T.

Nihon Naika Gakkai Zasshi. 2011 Aug 10;100(8):2177-86. Review. Japanese. No abstract available.

PMID:
21899149
[PubMed - indexed for MEDLINE]
15.

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications.

Ferreira LK, Busatto GF.

Clinics (Sao Paulo). 2011;66 Suppl 1:19-24. Review.

PMID:
21779719
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

New developments in the diagnosis of dementia.

Eschweiler GW, Leyhe T, Klöppel S, Hüll M.

Dtsch Arztebl Int. 2010 Oct;107(39):677-83. doi: 10.3238/arztebl.2010.0677. Epub 2010 Oct 1. Review.

PMID:
20963198
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease.

Vandenberghe R, Adamczuk K, Van Laere K.

Curr Opin Neurol. 2013 Dec;26(6):646-55. doi: 10.1097/WCO.0000000000000036. Review.

PMID:
24145484
[PubMed - indexed for MEDLINE]
18.

Role of biochemical Alzheimer's disease biomarkers as end points in clinical trials.

Siemers E, DeMattos RB, May PC, Dean RA.

Biomark Med. 2010 Feb;4(1):81-9. Review.

PMID:
20387304
[PubMed - indexed for MEDLINE]
19.

[Biological markers in the diagnosis of dementia and Alzheimer's disease].

Meiner Z, Rosenmann H.

Harefuah. 2012 May;151(5):289-93, 318. Review. Hebrew.

PMID:
22844733
[PubMed - indexed for MEDLINE]
20.

Identifying earlier Alzheimer's disease: insights from the preclinical and prodromal phases.

Molinuevo JL, Sánchez-Valle R, Lladó A, Fortea J, Bartrés-Faz D, Rami L.

Neurodegener Dis. 2012;10(1-4):158-60. doi: 10.1159/000332806. Epub 2011 Dec 7. Review.

PMID:
22156554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk